ICON (ICLR)
(Delayed Data from NSDQ)
$294.31 USD
+6.08 (2.11%)
Updated Apr 22, 2024 11:56 AM ET
After-Market: $299.50 +5.19 (1.76%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth B Momentum C VGM
Icon PLC (ICLR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$346.08 | $385.00 | $292.00 | 20.07% |
Price Target
Based on short-term price targets offered by 13 analysts, the average price target for Icon PLC comes to $346.08. The forecasts range from a low of $292.00 to a high of $385.00. The average price target represents an increase of 20.07% from the last closing price of $288.23.
Analyst Price Targets (13)
Broker Rating
Icon PLC currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on 14 recommendations.
Of the 14 recommendations deriving the current ABR, 14 are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 14 | 14 | 14 | 13 | 13 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/4/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Strong Buy | Strong Buy |
4/4/2024 | Robert W. Baird & Co. | Eric W Coldwell | Strong Buy | Strong Buy |
2/23/2024 | Evercore Partners | Elizabeth Anderson | Not Available | Strong Buy |
12/15/2023 | Truist Securities | Jailendra Singh | Strong Buy | Strong Buy |
10/25/2023 | William Blair | Maxwell A Smock | Strong Buy | Strong Buy |
9/18/2023 | Guggenheim Securities | Jack D Wallace | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 14 |
Average Target Price | $346.08 |
LT Growth Rate | 14.70% |
Industry | Medical Services |
Industry Rank by ABR | 89 of 252 |
Current Quarter EPS Est: | 3.44 |